Tech Company Financing Transactions

Orca Bio Funding Round

Lightspeed Venture Partners, 8VC and Data Collective participated in a $192 million Series D venture round for Orca Bio. This venture round was announced on 6/19/2020.

Transaction Overview

Company Information

Company Status

Private & Independent

Industry

Biopharmaceutical

Mailing Address

3475 Edison Way C
Menlo Park, CA 94025
USA

Phone

Undisclosed

Website

www.orcabio.com

Email Address

[email protected]

Overview

Established in 2016, Orca Bio is a clinical-stage biotechnology company developing a pipeline of high-precision allogeneic cell therapy products. Our products are designed to safely and effectively replace a patient's diseased blood and immune system with a healthy one.

Profile

Social Media

Company News

Facebook

YouTube

Management Team

Title

Name

Email & Social

Chief Executive Officer

Ivan Dimov

        

Chief Scientific Officer

Nathaniel Fernhoff

        

Chief Scientific Officer

James McClellan

        

VP - Engineering

Khiem Do

        

Browse more venture capital transactions:

Prev: 6/19/2020: Copado venture capital transaction
Next: 6/19/2020: Kaia Health venture capital transaction

Share this article

Where The Data Comes From

Our team works diligently to document all VC transactions involving tech companies. VC investment data records reported here come from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary